These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1884371)

  • 21. Genetic alterations in HCA-induced tumors.
    Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
    Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare activation of the human c-Ha-ras transgene of mice in hemangioendothelial sarcomas and liver tumors induced by Glu-P-1.
    Inoue R; Ushijima T; Katami M; Kushida H; Wakabayashi K; Sato H; Asamoto M; Katsuki M; Sugimura T; Nagao M
    Jpn J Cancer Res; 1996 Jun; 87(6):583-8. PubMed ID: 8766521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression.
    Brown K; Buchmann A; Balmain A
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):538-42. PubMed ID: 2105486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activating mutations in human c-Ha-ras-1 gene induced by reactive derivatives of safrole and the glutamic pyrolysis product, Glu-P-3.
    Ireland CM; Cooper CS; Marshall CJ; Hebert E; Phillips DH
    Mutagenesis; 1988 Sep; 3(5):429-35. PubMed ID: 3070278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases.
    Schmeiser HH; Frei E; Wiessler M; Stiborova M
    Carcinogenesis; 1997 May; 18(5):1055-62. PubMed ID: 9163696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse.
    Wiseman RW; Stowers SJ; Miller EC; Anderson MW; Miller JA
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5825-9. PubMed ID: 3016723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activating point mutation in Ki-ras codon 63 in a chemically induced rat renal tumor.
    Higinbotham KG; Rice JM; Perantoni AO
    Mol Carcinog; 1992; 5(2):136-9. PubMed ID: 1554412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator.
    Hegi ME; Fox TR; Belinsky SA; Devereux TR; Anderson MW
    Carcinogenesis; 1993 Jan; 14(1):145-9. PubMed ID: 8425263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.
    Devereux TR; Foley JF; Maronpot RR; Kari F; Anderson MW
    Carcinogenesis; 1993 May; 14(5):795-801. PubMed ID: 8504471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and K-Ras mutant fraction.
    Wang Y; Meng F; Arlt VM; Mei N; Chen T; Parsons BL
    Mutagenesis; 2011 Sep; 26(5):619-28. PubMed ID: 21642617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
    Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
    Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice.
    Anna CH; Maronpot RR; Pereira MA; Foley JF; Malarkey DE; Anderson MW
    Carcinogenesis; 1994 Oct; 15(10):2255-61. PubMed ID: 7955063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tumour promoters dieldrin and phenobarbital increase the frequency of c-Ha-ras wild-type, but not of c-Ha-ras mutated focal liver lesions in male C3H/He mice.
    Bauer-Hofmann R; Buchmann A; Mahr J; Kress S; Schwarz M
    Carcinogenesis; 1992 Mar; 13(3):477-81. PubMed ID: 1312398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of activated proto-oncogenes in N-nitrosodiethylamine-induced liver tumors: a comparison between B6C3F1 mice and Fischer 344 rats.
    Stowers SJ; Wiseman RW; Ward JM; Miller EC; Miller JA; Anderson MW; Eva A
    Carcinogenesis; 1988 Feb; 9(2):271-6. PubMed ID: 2827904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice.
    Hansen LA; Trempus CS; Mahler JF; Tennant RW
    Carcinogenesis; 1996 Sep; 17(9):1825-33. PubMed ID: 8824502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activating mutations in human c-Ha-ras-1 protooncogene induced by stereoisomeric fjord-region benzo[c]chrysene diol-epoxides.
    Du MQ; Seidel A; Phillips DH
    Mol Carcinog; 1995 Nov; 14(3):160-9. PubMed ID: 7576108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
    Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
    Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low oxygen tension, as found in tissues in vivo, alters the mutagenic activity of aristolochic acid I and II in primary fibroblast-like rat cells in vitro.
    Maier P; Schawalder H; Weibel B
    Environ Mol Mutagen; 1987; 10(3):275-84. PubMed ID: 3678207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
    Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
    Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.